CLINICAL_TRIALS
trial_result
· 2009-02-24
Clinical Trial Update: OC000459 Dose Finding Study in Hay Fever Sufferers. [Phase 2]
Summary
A completed Phase 2 dose-finding study of OC000459 for allergic rhinitis (hay fever) conducted by Oxagen Ltd. The study status is COMPLETED.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oxagen Ltd | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED